Millennium Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Millennium Management’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-34,080	Closed	-$3.32M	–	4206
2015 Q1	$3.32M	Sell	34,080 -53,978	-61%	-$5.71M	0.01%	1645
2014 Q4	$8.17M	Buy	88,058 +17,635	+25%	+$1.39M	0.02%	1113
2014 Q3	$4.84M	Buy	+70,423	New	+$5.04M	0.01%	1309
2014 Q2	–	Sell	-100	Closed	-$8.51K	–	4237
2014 Q1	$8K	Sell	100 -71,390	-100%	-$6.6M	﹤0.01%	3394
2013 Q4	$4.63M	Buy	+71,490	New	+$4.24M	0.01%	1234
2013 Q3	–	Sell	-108,443	Closed	-$5.34M	–	3783
2013 Q2	$4.55M	Buy	+108,443	New	+$4.94M	0.01%	1084

Millennium Management's GEVA Position: Q2 2015 in Review

Millennium Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 34,080 shares — an estimated $3.32M sold.

Millennium Management first reported a position in GEVA in Q2 2013 and held it in 6 quarters. The position peaked at $8.17M in Q4 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Millennium Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Millennium Management sold 34,080 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $3.32M.
Millennium Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 6 quarters.
Millennium Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $8.17M in Q4 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.